NCT04302597

Brief Summary

Recent clinical trials were developed to test the outcomes of skin closure with tissue adhesive, staples and monofilament synthetic suture after cesarean section with Pfannenstiel incision: both clinical outcomes such as blood loss, surgical site infection, length of postpartum hospitalization, or wound disruption, as well as Patient and Observer Scar Assessment Scale (POSAS) scores 8 weeks after surgery, were comparable between these different skin closure methods. Despite the available studies are often based on robust methodologies and appropriate assessment scales, most of them were aimed to evaluate cosmetic outcomes in primary cesarean section, whereas data analyses published so far do not allow to draw a firm conclusion about repeated cesarean sections. Based on these elements, the aim of this study is to evaluate cosmetic outcomes after skin closure of Pfannenstiel incision with tissue adhesive or staples in a selected population undergoing repeated cesarean section.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 10, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

May 15, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2021

Completed
Last Updated

September 8, 2021

Status Verified

August 1, 2021

Enrollment Period

9 months

First QC Date

March 5, 2020

Last Update Submit

August 31, 2021

Conditions

Keywords

Cesarean deliveryCosmesisHealingSkin closureScar assessment scales

Outcome Measures

Primary Outcomes (1)

  • Observer Scar Assessment Scale (OSAS) score

    The Observer Scar Assessment Scale (OSAS) rates 5 variables: vascularity, pigmentation, thickness, relief, and pliability. Each variable uses a 10-point scoring system, with 1 representing normal skin. Ratings of individual variables may be summed to obtain a total score ranging from 5-50, with 5 representing normal skin.

    6 months after repeated cesarean section

Secondary Outcomes (1)

  • Patient Scar Assessment Scale (PSAS) score

    6 months after repeated cesarean section

Study Arms (2)

Staples

ACTIVE COMPARATOR

Women who underwent repeated cesarean section with skin closure using staples.

Procedure: Staples

Tissue adhesive

EXPERIMENTAL

Women who underwent repeated cesarean section with skin closure using 2-octylcyanoacrylate tissue adhesive.

Procedure: Tissue adhesive

Interventions

StaplesPROCEDURE

Skin closure using surgical stapler.

Staples

Skin closure using 2-octylcyanoacrylate tissue adhesive.

Tissue adhesive

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Previous cesarean section with Pfannenstiel incision (regardless of the indication, emergency/urgency, weeks of pregnancy and years passed from the previous cesarean section)
  • Maternal age 18-45 years
  • Singleton pregnancy at 37-41 weeks of gestation (based on first-trimester ultrasound) with a viable fetus

You may not qualify if:

  • History of keloids
  • Previous transversal suprapubic scars
  • Clinical signs of infection and/or tattoos in the area to be studied
  • Known patient hypersensitivity to any of the suture materials used in the protocol
  • BMI below 20 or above 30
  • Any medical disorder that could affect wound healing, including severe malnutrition, conditions requiring chronic corticosteroid use or immune suppressant, uncontrolled diabetes mellitus (defined as Hemoglobin A1c \> 6%, unbalanced daily glucose measurements, and fasting glucose \>95 mg/dL).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ospedale "Filippo Del Ponte"

Varese, Lombardy, 21100, Italy

Location

MeSH Terms

Interventions

SuturesTissue Adhesives

Intervention Hierarchy (Ancestors)

Surgical Fixation DevicesSurgical EquipmentEquipment and SuppliesBiomedical and Dental MaterialsSpecialty Uses of ChemicalsChemical Actions and UsesManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Antonella Cromi, M.D., Ph.D.

    Università degli Studi dell'Insubria

    PRINCIPAL INVESTIGATOR
  • Fabio Ghezzi, M.D.

    Università degli Studi dell'Insubria

    STUDY CHAIR
  • Antonio Simone Laganà, M.D., Ph.D.

    Università degli Studi dell'Insubria

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single-center, prospective, randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 5, 2020

First Posted

March 10, 2020

Study Start

May 15, 2020

Primary Completion

January 30, 2021

Study Completion

July 15, 2021

Last Updated

September 8, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations